A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results.
<h4>Background</h4>B. anthracis anti-toxin agents are approved and included in the Strategic National Stockpile based primarily on animal infection trials. However, in the only anthrax outbreak an approved anti-toxin agent was administered in, survival did not differ comparing recipients...
Saved in:
| Main Authors: | Wanying Xu, Lernik Ohanjanian, Junfeng Sun, Xizhong Cui, Dante Suffredini, Yan Li, Judith Welsh, Peter Q Eichacker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0182879 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Obesity on Outcome in Preclinical Animal Models of Infection and Sepsis: A Systematic Review and Meta-Analysis
by: Wanying Xu, et al.
Published: (2020-01-01) -
Prospects for the use of <i>Bacillus anthracis</i> toxin in cancer therapy
by: A. P. Rodionov, et al.
Published: (2022-12-01) -
Toxin and capsule production by Bacillus cereus biovar anthracis influence pathogenicity in macrophages and animal models.
by: Treenate Jiranantasak, et al.
Published: (2024-12-01) -
Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.
by: Sunil K Joshi, et al.
Published: (2009-09-01) -
Preventing Foodborne Illness: Bacillus cereus and Bacillus anthracis
by: Keith R. Schneider, et al.
Published: (2005-02-01)